Table of Contents

company-logo

Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1). It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is headquartered in Bridgewater, New Jersey.

Tharimmune Dividend Announcement

• Tharimmune does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Tharimmune dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Tharimmune Dividend History

Tharimmune Dividend Yield

Tharimmune current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Tharimmune stock? Use our calculator to estimate your expected dividend yield:

Tharimmune Financial Ratios

P/E ratio-0.35
PEG ratio-0.00
P/B ratio1.26
ROE-167.63%
Payout ratio0.00%
Current ratio2.35
Quick ratio2.35
Cash Ratio2.14

Tharimmune Dividend FAQ

Does Tharimmune stock pay dividends?
Tharimmune does not currently pay dividends to its shareholders.
Has Tharimmune ever paid a dividend?
No, Tharimmune has no a history of paying dividends to its shareholders. Tharimmune is not known for its dividend payments.
Why doesn't Tharimmune pay dividends?
There are several potential reasons why Tharimmune would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Tharimmune ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Tharimmune has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Tharimmune a dividend aristocrat?
Tharimmune is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Tharimmune a dividend king?
Tharimmune is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Tharimmune a dividend stock?
No, Tharimmune is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Tharimmune stocks?
To buy Tharimmune you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Tharimmune stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.